Doi:10.1016/j.clpt.2005.12.178
American Society for Clinical Pharmacology and Therapeutics RIMONABANT PHARMACOKINETICS IN HEALTHY ANDCYP3A5 BUT NOT CYP2D6 POLYMORPHISM AFFECTSOBESE SUBJECTS. S. Turpault, V. Kanamaluru, G. F. Lockwood,DEXTROPROPOXYPHENE DISPOSITION IN HUMAN SUB-D. Bonnet, J. Newton, sanofi-aventis, Malvern, PA. JECTS. M. S. Chow, PharmD, O. Q. Yin, PhD, B. Tomlinson, MD, BACKGROUND: Rimonabant is the fi